Search

Search Results
Results 31 - 40 of 511 for breast cancer
  • Kisqali
    Drug - 11 Mar 2025
    Consumer Medicine Information (CMI) about Kisqali intended for persons living in Australia.
  • Navelbine Oral
    Drug - 5 Dec 2024
    Consumer Medicine Information (CMI) about Navelbine Oral intended for persons living in Australia.
  • Zelboraf
    Drug - 7 Apr 2020
    Consumer Medicine Information (CMI) about Zelboraf (vemurafenib) intended for persons living in Australia.
  • Premarin
    Drug - 14 Feb 2025
    Consumer Medicine Information (CMI) about Premarin (Conjugated estrogens Tablets) intended for persons living in Australia.
  • Evista
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Evista intended for persons living in Australia.
  • Brooke
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooke (drospirenone 3 mg and ethinylestradiol 20 micrograms) intended for persons living in Australia.
  • Brooklynn
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooklynn (drospirenone 3 mg and ethinylestradiol 30 micrograms) intended for persons living in Australia.
  • Seasonique
    Drug - 17 Dec 2024
    Consumer Medicine Information (CMI) about Seasonique intended for persons living in Australia.
  • Navelbine IV
    Drug - 5 Dec 2024
    Consumer Medicine Information (CMI) about Navelbine IV intended for persons living in Australia.
  • Piqray
    Drug - 21 Nov 2024
    Consumer Medicine Information (CMI) about Piqray intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback